Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Skye Bioscience, Inc. - Common Stock (NQ:SKYE)

3.925 +0.175 (+4.67%)
Streaming Delayed Price Updated: 2:04 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 392,459
Open 3.930
Bid (Size) 3.890 (2)
Ask (Size) 3.960 (1)
Prev. Close 3.750
Today's Range 3.760 - 4.060
52wk Range 1.140 - 7.110
Shares Outstanding 417,247,333
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data
Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk. 
Via Benzinga
Skye (SKYE) Q2 R&D Soars 249% No Revenue
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+37.7%
+37.7%
1 Month
+3.6%
+3.6%
3 Month
+82.6%
+82.6%
6 Month
+52.7%
+52.7%
1 Year
-34.5%
-34.5%

More News

Read More
Earnings Scheduled For August 7, 2025
Via Benzinga
In today's session, these stocks are experiencing unusual volume.
Via Chartmill
What's going on in today's session
Via Chartmill
Earnings Scheduled For May 8, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Which stocks are experiencing notable movement on Monday?
Via Chartmill
These stocks are moving in today's pre-market session
Via Chartmill
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News
Via Stocktwits
Topics Animal Testing Artificial Intelligence Stocks
Top stock movements in today's session.
Via Chartmill
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Tuesday's session.
Via Chartmill
Crude Oil Moves Lower; Citigroup Posts Upbeat Results
Via Benzinga
Nasdaq Surges 100 Points; Bank of America Earnings Top Views
Via Benzinga
Earnings Scheduled For March 20, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Top Picks For 2025: Skye Bioscience
Via Talk Markets
Topics Stocks / Equities
MarketBeat Week in Review – 10/7 - 10/11
Via MarketBeat
Topics Artificial Intelligence Economy
Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar
Via MarketBeat
3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore
Via MarketBeat
Topics Bankruptcy
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
Via Benzinga

Frequently Asked Questions

Is Skye Bioscience, Inc. - Common Stock publicly traded?
Yes, Skye Bioscience, Inc. - Common Stock is publicly traded.
What exchange does Skye Bioscience, Inc. - Common Stock trade on?
Skye Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Skye Bioscience, Inc. - Common Stock?
The ticker symbol for Skye Bioscience, Inc. - Common Stock is SKYE on the Nasdaq Stock Market
What is the current price of Skye Bioscience, Inc. - Common Stock?
The current price of Skye Bioscience, Inc. - Common Stock is 3.925
When was Skye Bioscience, Inc. - Common Stock last traded?
The last trade of Skye Bioscience, Inc. - Common Stock was at 09/05/25 02:04 PM ET
What is the market capitalization of Skye Bioscience, Inc. - Common Stock?
The market capitalization of Skye Bioscience, Inc. - Common Stock is 1.64B
How many shares of Skye Bioscience, Inc. - Common Stock are outstanding?
Skye Bioscience, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.